Current role
Enrique Poradosu
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nuvectis Pharma, Inc. (NVCT)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Nuvectis Pharma, Inc. (NVCT) | Chief Scientific & Business Officer | $483,381 | $1,586,241 |
| 2024 | Nuvectis Pharma, Inc. (NVCT) | Chief Scientific & Business Officer | $468,847 | $1,814,813 |
| 2023 | Nuvectis Pharma, Inc. (NVCT) | Chief Scientific & Business Officer | $454,750 | $1,563,400 |
| 2022 | Nuvectis Pharma, Inc. (NVCT) | Chief Scientific & Business Officer | $349,072 | $970,272 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.